Beauty
Health
Lifestyle
Medicine
Biowatch
Column
Kormedi.com TV
Notice
Newsletter subscription
Beauty
Health
Lifestyle
Medicine
Biowatch
Column
Kormedi.com TV
Notice
Languages
ENGLISH
English (US)
ASIAN
Монгол
日本語
Tiếng Việt
Bahasa Indonesia
中文 (简体, 中国大陆)
EUROPEAN
Русский
Español (España)
Français (France)
MIDDLE_EAST_AFRICA
العربية
Search results for "Phase 3 trial"
Home
SK Bioscience Secures First EU-Led Vaccine Project in Landmark Triple Consortium
SK Bioscience announced on February 26th that a tripartite consortium including the company has been selected for the first phase of a...
03/02/2026, 03:18 ET
Hanmi’s 'Amoprel' Makes Global Waves: World’s First Ultra-Low Triple Hypertension Drug Lands in JACC
The Phase 3 clinical trial results for Hanmi Pharmaceutical’s Amoprel—the world’s first ultra-low-dose triple antihypertensive drug—were published on...
03/01/2026, 03:19 ET
VigenCell "Primary Endpoint Achieved"... Will a Domestic NK/T Lymphoma New Drug Be Born?
VigenCell has announced plans to apply for conditional approval within the year as it successfully completed...
02/28/2026, 20:17 ET
The "Off Switch" for Itching: Why Some People Can’t Stop Scratching
When you scratch an itch, there is usually a natural moment when your hand stops. This isn't necessarily because the...
02/26/2026, 03:51 ET
K-Bio Targets Global Expansion: HK inno.N and HLB Seek FDA Approval
South Korean pharmaceutical and biotech companies are aggressively pursuing product approvals and clinical trials with...
02/18/2026, 04:26 ET
High Efficacy and Increased Convenience: The Three Obesity Drugs Awaiting FDA Approval
Since the World Health Organization recommended the use of obesity medications for adults last December, the market is...
02/06/2026, 03:39 ET
Eubiologics Reports Net Profit for Two Consecutive Years, What’s Next?
Cholera vaccine specialist Eubiologics has shown strong performance growth, recording net profits for two consecutive...
02/05/2026, 04:06 ET
New Discovery of Diabetes Drug Metformin: Long COVID Symptoms May Disappear
Among people infected with COVID-19, about 1 in 4 report experiencing symptoms of Long COVID, such as fatigue, brain...
02/04/2026, 02:56 ET
Dementia Injection Drug ‘Lecanemab’ Formulation and Dosage Diversification... Will It Compete with Oral Medications?
American Biogen and Japanese Eisai are moving quickly to change the formulation and dosage of the dementia treatment...
01/29/2026, 04:48 ET
K-Toxins Heading to China... Will Hugel Be Followed After 5 Years in the Top 3?
Domestic botulinum toxin companies are racing towards the Chinese market. With Hugel, which entered China first,...
01/26/2026, 05:30 ET
Previous
8
9
10
11
Next